Quarterly Call Option Transactions in Bio Xcel Therapeutics, Inc. (BTAI)
This table provides information about the institutional ownership of Bio Xcel Therapeutics, Inc. (BTAI) during . The information is specifically focused on institutions that hold call options of BioXcel Therapeutics, Inc..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 28,300 | 0 | 28,300 | — | 28,300 | |||
| Q4 2021 | 3,900 | 10,800 | 14,700 | 92,100 | 0 | 92,100 | -77,400 | |
| Q1 2022 | 38,700 | 0 | 38,700 | 0 | 10,800 | 10,800 | 27,900 | |
| Q2 2022 | 9,300 | 5 | 9,305 | 53,300 | 0 | 53,300 | -43,995 | |
| Q3 2022 | 25,500 | 0 | 25,500 | 10,000 | 0 | 10,000 | 15,500 | |
| Q4 2022 | 500 | 0 | 500 | 20,300 | 0 | 20,300 | -19,800 | |
| Q1 2023 | 69,000 | 116,100 | 185,100 | 53,200 | 0 | 53,200 | 131,900 | |
| Q2 2023 | 109,600 | 761,500 | 871,100 | 61,200 | 0 | 61,200 | 809,900 | |
| Q3 2023 | 289,800 | 0 | 289,800 | 65,800 | 0 | 65,800 | 224,000 | |
| Q4 2023 | 24,100 | 0 | 24,100 | 310,200 | 0 | 310,200 | -286,100 | |
| Q1 2024 | 49,600 | 0 | 49,600 | 45,600 | 0 | 45,600 | 4,000 | |
| Q2 2024 | 15,900 | 0 | 15,900 | — | 15,900 | |||
| Q3 2024 | 1,700 | 0 | 1,700 | — | 1,700 | |||